| Line item | 2025-12-31 FY | 2025-09-30 FY | 2025-06-30 FY | 2025-03-31 FY | 2024-12-31 FY | 2024-09-30 FY | 2024-06-30 FY | 2024-03-31 FY |
|---|---|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – | – | – |
| Operating Expenses | $9.77M | – | – | – | $5.92M | – | – | – |
| R&D | – | – | – | – | – | – | – | – |
| SG&A | – | – | – | – | – | – | – | – |
| Operating Income | -$9.77M | -$2.77M | -$2.44M | -$2.37M | -$5.83M | -$1.51M | -$1.55M | -$628.00K |
| Interest Expense | – | – | – | – | – | – | – | – |
| Tax Expense | – | – | – | – | – | – | – | – |
| Net Income | -$222.30M | $317.67M | $1.20B | -$587.59M | $1.89B | $46.10M | -$409.21M | $844.61M |
| EPS (basic) | – | – | – | – | – | – | – | – |
| EPS (diluted) | – | – | – | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – | – | – | – |